Indian equities posted their steepest weekly fall in seven months as the Sensex and Nifty extended losses amid U.S. visa curbs and drug tariffs. Pharma and IT stocks dragged, while FIIs stayed cautious. Analysts flagged key support at 24,500, with volatility expected around monthly expiry and global uncertainties weighing on sentiment.
Positive Breakout: These 9 stocks cross above their 200 DMAs
In the Nifty 500 pack, 15 stocks saw their closing prices cross above their 200-day moving average (DMA) on July 1, 2026. Of these, we
July 2, 2026